IL6 and hypertensive disorder: In clinical studies, middle-aged and elderly participants with hypertension who were administered a daily dose of 2 g EPA + DHA for 90 days exhibited reduced plasma levels of CRP and Tnfα, while Il6 levels remained unaffected [41].